{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:25:59Z","timestamp":1782887159619,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40121-021-00578-5","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T16:03:00Z","timestamp":1639670580000},"page":"451-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Awareness and Epidemiology of Chronic Hepatitis C Virus Infections in Florida"],"prefix":"10.1007","volume":"11","author":[{"given":"Emmanuel","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Han","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Dylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Carabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"issue":"3","key":"578_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"Polaris Observatory HCVC","year":"2017","unstructured":"Polaris Observatory HCVC. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"578_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/hep4.1049","volume":"1","author":"N Reau","year":"2017","unstructured":"Reau N, Vekeman F, Wu E, Bao Y, Gonzalez YS. Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy. Hepatol Commun. 2017;1(5):439\u201352.","journal-title":"Hepatol Commun"},{"key":"578_CR3","unstructured":"CDC. Viral hepatitis surveillance 2019. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2017surveillance\/index.htm. Accessed Mar 2021."},{"issue":"8","key":"578_CR4","doi-asserted-by":"publisher","first-page":"e186371","DOI":"10.1001\/jamanetworkopen.2018.6371","volume":"1","author":"ES Rosenberg","year":"2018","unstructured":"Rosenberg ES, Rosenthal EM, Hall EW, Barker L, Hofmeister MG, Sullivan PS, et al. Prevalence of hepatitis C virus infection in US States and the District of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1(8):e186371\u2013471.","journal-title":"JAMA Netw Open"},{"key":"578_CR5","unstructured":"WHO. Global hepatitis report 2017. http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/. Accessed Sept 2021."},{"key":"578_CR6","unstructured":"AASLD-IDSA. Management of acute HCV infection. Key populations: identification and management of HCV in people who inject drugs. https:\/\/www.hcvguidelines.org\/unique-populations\/pwid. Accessed Sept 2021."},{"issue":"2","key":"578_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175\u201381.","journal-title":"Am J Public Health"},{"issue":"2","key":"578_CR8","first-page":"1","volume":"69","author":"S Schillie","year":"2020","unstructured":"Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults - United States, 2020. MMWR Recomm Rep Morb Mortal Wkly Rep. 2020;69(2):1\u201317.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep"},{"key":"578_CR9","unstructured":"AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. http:\/\/www.hcvguidelines.org\/full-report\/hcv-testing-and-linkage-care. Accessed Sept 2021."},{"issue":"10","key":"578_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2020.1123","volume":"323","author":"UPST Force","year":"2020","unstructured":"Force UPST. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(10):970\u20135.","journal-title":"JAMA"},{"issue":"3","key":"578_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/hep4.1457","volume":"4","author":"H Bradley","year":"2020","unstructured":"Bradley H, Hall EW, Rosenthal EM, Sullivan PS, Ryerson AB, Rosenberg ES. Hepatitis C virus prevalence in 50 U.S. States and D.C. by sex, birth cohort, and race: 2013\u20132016. Hepatol Commun. 2020;4(3):355\u201370.","journal-title":"Hepatol Commun"},{"key":"578_CR12","unstructured":"HHS. Hepatitis C disparities among African Americans 2017. https:\/\/www.hhs.gov\/hepatitis\/blog\/2017\/02\/27\/hepatitis-c-disparities-among-african-americans.html. Accessed Mar 2021."},{"issue":"1","key":"578_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12954-019-0313-7","volume":"16","author":"D Crowley","year":"2019","unstructured":"Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T, et al. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners. Harm Reduct J. 2019;16(1):42.","journal-title":"Harm Reduct J"},{"issue":"3","key":"578_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.24875\/AIDSRev.M17000006","volume":"19","author":"AC Spaulding","year":"2017","unstructured":"Spaulding AC, Anderson EJ, Khan MA, Taborda-Vidarte CA, Phillips JA. HIV and HCV in U.S. prisons and jails: the correctional facility as a bellwether over time for the community\u2019s infections. AIDS Rev. 2017;19(3):134\u201347.","journal-title":"AIDS Rev"},{"issue":"3","key":"578_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1078345816653875","volume":"22","author":"GE Iba\u00f1ez","year":"2016","unstructured":"Iba\u00f1ez GE, Whitt E, Rosa MDL, Martin S, O\u2019Connell D, Castro J. Developing a culturally appropriate HIV and hepatitis C prevention intervention for latino criminal justice clients. J Correct Healthc. 2016;22(3):206\u201317.","journal-title":"J Correct Healthc"},{"issue":"4","key":"578_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10903-019-00931-4","volume":"22","author":"R Auf","year":"2020","unstructured":"Auf R, Cano M, Selim M, O\u2019Connell D, Martin S, Iba\u00f1ez GE. Hepatitis C virus and hispanic criminal justice clients: a missed opportunity. J Immigr Minor Health. 2020;22(4):701\u20137.","journal-title":"J Immigr Minor Health"},{"issue":"10178","key":"578_CR17","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(18)32277-3","volume":"393","author":"A Heffernan","year":"2019","unstructured":"Heffernan A, Cooke GS, Nayagam S, Thursz M, Hallett TB. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. Lancet. 2019;393(10178):1319\u201329.","journal-title":"Lancet"},{"issue":"3\u20134","key":"578_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1108\/IJPH-07-2016-0028","volume":"13","author":"MD Morris","year":"2017","unstructured":"Morris MD, Brown B, Allen SA. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health. Int J Prison Health. 2017;13(3\u20134):192\u20139.","journal-title":"Int J Prison Health"},{"key":"578_CR19","unstructured":"WHO. Global health sector strategy on viral hepatitis 2016\u20132021 2020. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06. Accessed Dec 2021."},{"key":"578_CR20","unstructured":"Florida Viral Hepatitis Planning Group. FHPP. The Florida hepatitis prevention action plan 2016\u20132020 2016. http:\/\/www.floridahealth.gov\/diseases-and-conditions\/hepatitis\/_documents\/hep-prevention-action-plan-2016.pdf. Accessed Sept 2021."},{"issue":"2","key":"578_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.aohep.2018.06.001","volume":"18","author":"M Malespin","year":"2019","unstructured":"Malespin M, Harris C, Kanar O, Jackman K, Smotherman C, Johnston A, et al. Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic. Ann Hepatol. 2019;18(2):304\u20139.","journal-title":"Ann Hepatol"},{"issue":"5","key":"578_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10900-017-0335-6","volume":"42","author":"EB Feldman","year":"2017","unstructured":"Feldman EB, Balise R, Schiff E, Whitehead N, Thomas E. Barriers to hepatitis C screening in a minority population: a comparison of hepatitis C and human immunodeficiency virus screening rates at a community STD clinic in Miami, Florida. J Community Health. 2017;42(5):921\u20135.","journal-title":"J Community Health"},{"issue":"7","key":"578_CR23","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s12325-018-0721-1","volume":"35","author":"VV Chirikov","year":"2018","unstructured":"Chirikov VV, Marx SE, Manthena SR, Strezewski JP, Saab S. Development of a comprehensive dataset of hepatitis C patients and examination of disease epidemiology in the United States, 2013\u20132016. Adv Ther. 2018;35(7):1087\u2013102.","journal-title":"Adv Ther"},{"issue":"12","key":"578_CR24","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1007\/s12325-021-01928-y","volume":"38","author":"N Reau","year":"2021","unstructured":"Reau N, Sulkowski MS, Thomas E, Sundaram V, Xu Q, Cheng WH, et al. Epidemiology and clinical characteristics of individuals with hepatitis C virus infection in the United States, 2017\u20132019. Adv Ther. 2021;38(12):5777\u201390.","journal-title":"Adv Ther"},{"key":"578_CR25","unstructured":"Florida Department of Health. Epidemiology of hepatitis B and C in Florida, 2019. 2021. http:\/\/www.floridahealth.gov\/diseases-and-conditions\/hepatitis\/hepatitis-general-information.html. Accessed Dec 2021."},{"key":"578_CR26","unstructured":"NVHR, CHLPI. Hepatitis C: state of Medicaid access 2020. http:\/\/stateofhepc.org. Accessed May 2021."},{"key":"578_CR27","unstructured":"Waters P, Greenwald R, Ninburg M, Simmons A. State policies limiting progress towards HCV elimination in the U.S. National Viral Hepatitis Roundtable. 2020."},{"issue":"1_suppl","key":"578_CR28","doi-asserted-by":"publisher","first-page":"44s","DOI":"10.1177\/0033354920904608","volume":"135","author":"R Greenwald","year":"2020","unstructured":"Greenwald R, Waters P, Cayer S. Enforcement of legal remedies to secure hepatitis C virus treatment with direct-acting antiviral therapies in correctional facilities and Medicaid programs. Public Health Rep. 2020;135(1_suppl):44s\u20139s.","journal-title":"Public Health Rep"},{"key":"578_CR29","unstructured":"MappingHepC. Interactive map 2020. https:\/\/mappinghepc.com\/maps. Accessed Sept 2021."},{"key":"578_CR30","unstructured":"Christ G. Ohio Department of Medicaid to treat those with Hepatitis C earlier. The Plain Dealer. 2018."},{"key":"578_CR31","unstructured":"MDHHS. Michigan\u2019s state plan on eliminating hepatitis C. 2021. https:\/\/www.michigan.gov\/documents\/mdhhs\/MDHHS_State_Plan_on_Eliminating_HCV_Final_Draft_720817_7.pdf. Accessed Dec 2021."},{"issue":"1","key":"578_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12967-018-1555-y","volume":"16","author":"A DeBose-Scarlett","year":"2018","unstructured":"DeBose-Scarlett A, Balise R, Kwon D, Vadaparampil S, Chen SX, Schiff ER, et al. Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population. J Transl Med. 2018;16(1):178.","journal-title":"J Transl Med"},{"key":"578_CR33","doi-asserted-by":"publisher","first-page":"576357","DOI":"10.3389\/fmicb.2021.576357","volume":"12","author":"DCS Im","year":"2021","unstructured":"Im DCS, Reddy S, Hawkins C, Galvin S. Characteristics and specialist linkage to care of patients diagnosed with chronic hepatitis C across different settings in an urban academic hospital: implications for improving diagnosis and linkage to care. Front Microbiol. 2021;12:576357.","journal-title":"Front Microbiol"},{"key":"578_CR34","unstructured":"Justia.com. Hoffer v. Secretary, Florida Departmental Corrections, No. 19-11921 (11th Cir. 2020) 2020. https:\/\/law.justia.com\/cases\/federal\/appellate-courts\/ca11\/19-11921\/19-11921-2020-08-31.html. Accessed Mar 2021."},{"key":"578_CR35","unstructured":"WUSF public media. Gov. DeSantis vetoes $1 billion from Florida budget, citing \u201cdifficult circumstances\u201d. https:\/\/wusfnews.wusf.usf.edu\/politics\/2020-06-29\/gov-desantis-vetoes-1-billion-from-florida-budget-citing-difficult-circumstances. Accessed Dec 2021."},{"issue":"2","key":"578_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.idc.2018.02.010","volume":"32","author":"TL Applegate","year":"2018","unstructured":"Applegate TL, Fajardo E, Sacks JA. Hepatitis C virus diagnosis and the Holy Grail. Infect Dis Clin N Am. 2018;32(2):425\u201345.","journal-title":"Infect Dis Clin N Am"},{"key":"578_CR37","unstructured":"Washington State Department of Health. Hep C free Washington: plan to eliminate hepatitis C in Washington State by 2030 2019. https:\/\/www.doh.wa.gov\/Portals\/1\/Documents\/Pubs\/150nonDOH-HepCFreeWA-PlanJuly2019.pdf. Accessed Dec 2021."},{"issue":"9","key":"578_CR38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S2468-1253(20)30238-7","volume":"5","author":"C Wingrove","year":"2020","unstructured":"Wingrove C, Ferrier L, James C, Wang S. The impact of COVID-19 on hepatitis elimination. Lancet Gastroenterol Hepatol. 2020;5(9):792\u20134.","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00578-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-021-00578-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00578-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:43:40Z","timestamp":1644947020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-021-00578-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1007\/s40121-021-00578-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}